Background If the lipid concentration is not taken into account, then in certain situations the vitamin E status of a patient may be wrongly assigned based on serum measurement alone. In this study, the utility of using the calculated vitamin E:cholesterol ratio to determine vitamin E status was compared to the measurement of vitamin E alone.
Introduction
In the past, vitamin E has often been referred to as a vitamin looking for a disease, and there have been many claims to its bene¢ts.Vitamin E is a potent antioxidant and, by preventing the oxidation of lipoprotein, it may have a role in preventing atheromatous plaque formation, although clinical trials have yet to con¢rm this. 1, 2 In both children and adults, vitamin E de¢ciency can result in spinocerebellar syndrome, which is characterized by progressive cerebellar ataxia and loss of proprioception. 3, 4 Patients particularly susceptible to vitamin E de¢ciency include those with cystic ¢brosis (CF), pancreatic insu⁄ciency and all types of liver disease, and monitoring these patients makes up to 98% of the requests for our regional vitamin E testing service.
Serum vitamin E concentration provides the simplest and most direct way of assessing vitamin E status.Vitamin E circulates in blood predominantly with low-density b-lipoproteins. 5 As the concentrations of serum lipids increase, vitamin E partitions out of the cellular membrane compartment into the circulating lipoproteins. Consequently, when serum lipid concentrations are elevated pathologically --for example in hepatic cholestasis --vitamin E de¢ciency may be missed if the lipid concentration is not taken into account. Conversely, vitamin E de¢ciency may be overestimated when serum lipid concentrations are low, such as in CF. 6 Drugs that e¡ect serum lipids such as statins and thyroid hormones may also have an e¡ect on vitamin E concentration. 6, 7 By expressing vitamin E as a ratio of circulating lipid concentration, a more accurate determination of patient vitamin E status is obtained.
LDL and b-lipoprotein analysis are not o¡ered routinely in most laboratories. As a practical alternative, standardization of vitamin E to an individual marker or a combination of several di¡erent markers of lipid concentration, including triglyceride, cholesterol and phospholipids, have been used instead. 6,8--10 Although there is no agreement on which lipid ratio should be used, for routine analysis the most practical choice is the individual lipid ratios. Of these, the determination of vitamin E:cholesterol ratio performs best when compared with the determination of vitamin E:total lipid ratios. 8 Serum cholesterol measurement also has the added advantage of being convenient to measure routinely, requires small sample volumes and is a¡ected to a lesser extent by pre-sampling factors such as the fasting status of the patient.
Carrying on from the work of Thurnham, 8 the utility of cholesterol-adjusted vitamin E in routine analysis has been assessed in this study using a large patient population.
Samples and methods
Serum samples (n ¼ 457) sent to our laboratory from all over the UK and Ireland for routine vitamin E analysis during the ¢rst six months of 2005 were used. Patient ages ranged from 11 days to 90 years, with a mean age of 18.5 years.
On receipt, samples were stored at 41C and analysed within three days.
Vitamin E concentration was determined using the method of Thurnham et al., which was optimized for routine analysis. 11 Brie£y, 250 mL of serum was added to a 10 mL screw top glass tube (L.I.P Equipment & Services Ltd., UK), together with 250 mL retinol acetate (800 mg/L prepared in absolute ethanol) and 750 mL of petroleum ether containing 0.04% (w/v) butylated hydroxy toluene (BHT, Sigma-Aldrich Poole, UK) and vortexed vigorously for 2 min. Samples were centrifuged at 2000 Â g for 10 min and the upper petroleum ether layer was transferred to a 15 mL evaporation tube (Zymark). The ether extracts were then evaporated to dryness at 251C for 5 min using a Zymark TurboVap LV evaporator. Extracts were reconstituted in 50 mL of dimethyl sulphoxide (DMSO) and vortex-mixed vigorously for 2 min. Mobile phase:chloroform mix (50:13) was added and the samples vortex-mixed for a further 2 min.
High-performance liquid chromatography (HPLC) analysis of vitamin E (80 mL) was performed using a Waters HPLC system, with aWaters 2487 Dual l Absorbance Detector, driven by Waters Breeze Software. The stationary phase used was a Phenomenex Prodigy 5 mm ODS2 column (C18, 150 mm Â 4.6 mm) main-tained at 351C and protected with a 4 mm Â 3 mm guard column (Phenomenex, UK). The mobile phase (£ow rate 1.5 mL/min) was methanol:acetonitrile: chloroform (47:47:6) containing 10 mg 2,6-di-tertbutyl-4-methylphenol (BHT) per litre.
At a vitamin E concentration of 18 mmol/L, the imprecision for the method was 1.9% (n ¼10) within runs and 9.8% (n ¼ 20) between runs.
Serum cholesterol was measured enzymatically using Roche Cholesterol CHOD-PAP reagents on a Roche Modular P analyser (Roche, Diagnostics Limited, East Sussex, UK).
Statistics and calculations
The data were analysed using MINITAB Statistical Software, Version 13 (MINITAB Inc, USA). Age-related reference intervals for vitamin E were established locally and are as follows: 11.5--24.4 mmol/L up to one year; 7.0--21.0 mmol/L from 2--6 years; 10.0--21.0 mmol/L from 7--12 years; 13.0--19.0 mmol/L from 13--19 years; and 9.5--41.5 mmol/L 419 years. Vitamin E:cholesterol ratios were calculated using the method of Thurnham, where a vitamin E:cholesterol ratio of o2.22 mmol/ mmol was taken as the threshold for vitamin E de¢ciency. 8 Results Table 1 compares the mean vitamin E:cholesterol ratio for the age-related reference intervals. The regression line between vitamin E concentration and vitamin E:cholesterol ratio was y ¼ 0.25x, R 2 ¼0.41, and is shown in Figure 1 .
Out of the 457 patient samples analysed, 57 (12.5%) were found to have a low vitamin E concentration according to our age-related reference ranges. Of these patients, 32 (56%) had a normal vitamin E:cholesterol ratio and 25 (44%) had a low vitamin E:cholesterol ratio (o2.22 mmol/mmol). Samples with concordance between low vitamin E concentration and the vitamin E:cholesterol ratio had a mean cholesterol concentration of 3.9 mmol/L (range 1.7--7.2 mmol/L). This was signi¢cantly higher compared with samples with a low vitamin E concentration but normal vitamin E:cholesterol ratio, which had a mean cholesterol concentration of 2.6 mmol/L (range 1.5--3.8 mmol/L).
Only two of the 457 patients studied were found to have a low vitamin E:cholesterol ratio but normal vitamin E concentration.
Discussion
The overall concordance between serum vitamin E concentration and vitamin E:cholesterol ratio was Ann Clin Biochem 2006; 43: 130-134 92%. For normal serum vitamin E status, the concordance between vitamin E concentration and vitamin E:cholesterol ratio was 99.5%. However, the agreement between vitamin E concentration and vitamin E:cholesterol ratios for vitamin E de¢ciency was only 42%. The age-related vitamin E reference intervals used in this study were established in the laboratory from local populations and, if set inappropriately low could explain this discordance. However, on examination, there was no indication that any of the age-related reference ranges used were set too low with no signi¢cant di¡erence between di¡erent age groups studied.Where there was disagreement between the vitamin E concentration and the vitamin E:cholesterol ratio, the cholesterol concentration was, predictably, signi¢cantly lower. Therefore, the true vitamin E status for over half the 57 patients in this study found to have a low vitamin E concentration is actually normal. This ¢nding is in agreement with a similar study carried out in the USA of 307 routine patient samples, which found the discordance for vitamin E de¢ciency between vitamin E concentration and vitamin E:(cholesterol þ triglyceride) ratios was 47%. 10 More than 50% of the patients found to have a low serum vitamin E concentration were tested as part of the annual review for CF. Only 24% of these CF patients had both a low vitamin E level and low vitamin E:cholesterol ratio. For these CF patients this provides indirect evidence of greater pancreatic exocrine activity, which has important prognostic implications and may mean patients do not require pancreatic supplementation. 12, 13 Patients with cholestasis accounted for another 21% of patients with low vitamin E concentration, and 60% of these had both low vitamin E levels and vitamin E:cholesterol ratio. All patients with progressive familial intrahepatic cholestasis (PFIC, n ¼ 4) had both a low serum vitamin E concentration and a low vitamin E:cholesterol ratio. Other reasons stated for testing patients found to have vitamin E de¢ciency in this study included pancreatic insu⁄ciency, liver transplant, protracted diarrhoea and night blindness. Only two out of the 457 patients studied were found to have both normal vitamin E concentration and low vitamin E:cholesterol ratio. One of these patients was a 20-week-old child with neonatal cholestasis (vitamin E concentration 13.4 mmol/L, cholesterol 6.8 mmol/L, vitamin E:cholesterol ratio 1.97 mmol/mmol). The other patient was a 53-year-old male also with cholestasis, (vitamin E concentration 18.4 mmol/L, cholesterol 8.6 mmol/L, vitamin E:cholesterol ratio 2.14 mmol/ mmol). There are further examples in the literature of patients with chronic cholestasis also exhibiting neurological signs of vitamin E de¢ciency, who on testing have been found to have a normal vitamin E concentration but a low vitamin E:cholesterol ratio. 14 It would therefore appear that in order to determine the true vitamin E status for patients with cholestasis, lipid adjustment of vitamin E is necessary regardless of the serum vitamin E concentration measured.
This study has provided further evidence to support the need for lipid adjustment of serum vitamin E measurements, but only in certain situations, when the vitamin E concentration is low to con¢rm vitamin E de¢ciency and for patients with speci¢c disease states such as cholestasis. For the majority of samples, measurement of serum vitamin E concentration alone is su⁄cient to establish actual patient vitamin E status. 
